Toshima-ku, Japan

Yuko Araki

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Toshima-ku, JP (2014)
  • Tokyo, JP (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yuko Araki: Innovator in Pharmaceutical Chemistry

Introduction

Yuko Araki is a prominent inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various neurological and psychological disorders. With a total of 4 patents to his name, Araki's work is paving the way for innovative treatments.

Latest Patents

One of Araki's latest patents is for a heteroaromatic methyl cyclic amine derivative. This compound is represented by formula (IA) or a pharmaceutically acceptable salt thereof. It is useful for the treatment or prophylaxis of diseases such as sleep disorder, depression, anxiety disorder, panic disorder, schizophrenia, drug dependence, Alzheimer's disease, Parkinson's disease, Huntington's disease, eating disorder, cephalalgia, hemicrania, pain, digestive diseases, epilepsy, inflammation, immune-related diseases, endocrine-related diseases, and hypertension, based on its orexin (OX) receptor antagonist activity. Another notable patent involves glycine transporter-inhibiting substances. These novel compounds, represented by formula [I] or pharmaceutically acceptable salts thereof, are beneficial in preventing or treating diseases such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders, depression, drug dependence, spasm, tremor, pain, Parkinson's disease, attention deficit hyperactivity disorder, bipolar disorder, eating disorder, and sleep disorders, due to their glycine uptake-inhibiting action.

Career Highlights

Yuko Araki is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention in the scientific community, contributing to advancements in mental health treatments.

Collaborations

Araki collaborates with notable colleagues, including Hiroshi Ohta and Kumi Abe, who contribute to his research and development efforts. Their combined expertise enhances the potential impact of their innovations in the pharmaceutical industry.

Conclusion

Yuko Araki's contributions to pharmaceutical chemistry are significant, particularly in the development of treatments for various neurological and psychological disorders. His innovative patents reflect a commitment to improving patient care and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…